Targeting connexin 43 protects against the progression of experimental chronic kidney disease in mice

Kidney International

Volumn 86, Issue 4, 2014, Pages 768-779

  Abed, Ahmed ^a,b   Toubas, Julie ^a,b   Kavvadas, Panagiotis ^a   Authier, Florence ^a   Cathelin, Dominique ^a   Alfieri, Carlo ^a,d   Boffa, Jean Jacques ^a,b   Dussaule, Jean Claude ^a,b,c   Chatziantoniou, Christos ^a,b   Chadjichristos, Christos E ^a,b  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

chronic kidney disease; fibrosis; inflammation

Indexed keywords

CHEMOKINE RECEPTOR; COLLAGEN TYPE 1; CONNEXIN 43; MITOGEN ACTIVATED PROTEIN KINASE; PADGEM PROTEIN; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1; ANTISENSE OLIGONUCLEOTIDE; CADHERIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EXPERIMENTAL DISEASE; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; HYPERTENSION; IMMUNOFLUORESCENCE; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MICROALBUMINURIA; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; FIBROSIS; GENETIC TRANSCRIPTION; GENETICS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION;

ALBUMINURIA; ANIMALS; CADHERINS; CELL ADHESION; COLLAGEN TYPE I; CONNEXIN 43; DISEASE PROGRESSION; DOWN-REGULATION; FIBROSIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MONOCYTES; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; RENAL INSUFFICIENCY, CHRONIC; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84926165196     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.108     Document Type: Article

References (44)

1. Harris RC, Neilson EG. Toward a unified theory of renal progression. Annu Rev Med 2006; 57: 365-380.
2. Dussaule JC, Chatziantoniou C. Reversal of renal disease: is it enough to inhibit the action of angiotensin II? Cell Death Differ 2007; 14: 1343-1349.
3. Chanson M, Derouette JP, Roth I et al. Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta 2005; 1711: 197-207.
4. Scheckenbach KE, Crespin S, Kwak BR et al. Connexin channel-dependent signaling pathways in inflammation. J Vasc Res 2011; 48: 91-103.
5. Saez JC, Berthoud VM, Branes MC et al. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003; 83: 1359-1400.
6. Sohl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res 2004; 62: 228-232.
7. Harris AL. Emerging issues of connexin channels: biophysics fills the gap. Q Rev Biophys 2001; 34: 325-472.
8. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 2003; 4: 285-294.
9. Bevans CG, Kordel M, Rhee SK et al. Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules. J Biol Chem 1998; 273: 2808-2816.
10. Wong CW, Christen T, Roth I et al. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 2006; 12: 950-954.
11. Chadjichristos CE, Matter CM, Roth I et al. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 2006; 113: 2835-2843.
12. Toubas J, Beck S, Pageaud AL et al. Alteration of connexin expression is an early signal for chronic kidney disease. Am J Physiol Renal Physiol 2011; 301: F24-F32.
13. Reaume AG, de Sousa PA, Kulkarni S et al. Cardiac malformation in neonatal mice lacking connexin43. Science 2005; 267: 1831-1834.
14. Liao Y, Day KH, Damon DN et al. Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci USA 2001; 98: 9989-9994.
15. Haefliger JA, Krattinger N, Martin D et al. Connexin43-dependent mechanism modulates renin secretion and hypertension. J Clin Invest 2006; 116: 405-413.
16. Figueroa XF, Isakson BE, Duling BR. Vascular gap junctions in hypertension. Hypertension 2006; 48: 804-811.
17. Chadjichristos CE, Morel S, Derouette JP et al. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res 2008; 102: 653-660.
18. Qiu C, Coutinho P, Frank S et al. Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 2003; 13: 1697-1703.
19. Cronin M, Anderson PN, Cook JE et al. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol Cell Neurosci 2008; 39: 152-160.
20. Nakano Y, Oyamada M, Dai P et al. Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo. Invest Ophthalmol Vis Sci 2008; 49: 93-104.
21. Guerrot D, Kerroch M, Placier S et al. Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. Am J Pathol 2001; 179: 83-91.
22. Milanini-Mongiat J, Pouysségur J, Pagès G. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 2002; 277: 20631-20639.
23. Kypriotou M, Beauchef G, Chadjichristos C et al. Human collagen Krox upregulates type I collagen expression in normal and scleroderma fibroblasts through interaction with Sp1 and Sp3 transcription factors. J Biol Chem 2007; 282: 32000-32014.
24. Huby AC, Kavvadas P, Alfieri C et al. The RenTg mice: a powerful tool to study renin-dependent chronic kidney disease. PLoS One 2012; 7: e52362.
25. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
26. Sarieddine MZ, Scheckenbach KL, Foglia B et al. Connexin43 modulates neutrophil recruitment to the lung. J Cell Mol Med 2009; 13: 4560-4570.
27. Ey B, Eyking A, Gerken G et al. TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury. J Biol Chem 2009; 284: 22332-22343.
28. Kwak BR, Mulhaupt F, Veillard N et al. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002; 22: 225-230.
29. Vé liz LP, González FG, Duling BR et al. Functional role of gap junctions in cytokine-induced leukocyte adhesion to endothelium in vivo. Am J Physiol Heart Circ Physiol 2008; 295: 1056-1066.
30. Sommer M, Eismann U, Deuther-Conrad W et al. Time course of cytokine mRNA expression in kidneys of rats with unilateral ureteral obstruction. Nephron 2000; 84: 49-57.
31. Asazuma-Nakamura Y, Dai P, Harada Y et al. Cx43 contributes to TGF-beta signaling to regulate differentiation of cardiac fibroblasts into myofibroblasts. Exp Cell Res 2009; 315: 1190-1199.
32. Hillis GS, Duthie LA, Brown PA et al. Upregulation and co-localization of connexin43 and cellular adhesion molecules in inflammatory renal disease. J Pathol 1997; 182: 373-379.
33. Yaoita E, Yao J, Yoshida Y et al. Up-regulation of connexin43 in glomerular podocytes in response to injury. Am J Pathol 2002; 161: 1597-1606.
34. Kwak BR, Veillard N, Pelli G et al. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptordeficient mice. Circulation 2003; 107: 1033-1039.
35. Thomas MA, Huang S, Cokoja A et al. Interaction of connexins with protein partners in the control of channel turnover and gating. Biol Cell 2002; 94: 445-456.
36. Maass K, Shibayama J, Chase SE et al. C-terminal truncation of connexin43 changes number, size, and localization of cardiac gap junction plaques. Circ Res 2007; 101: 1283-1291.
37. Parthasarathi K, Ichimura H, Monma E et al. Connexin 43 mediates spread of Ca2-dependent proinflammatory responses in lung capillaries. J Clin Invest 2006; 116: 2193-2200.
38. Hirschi KK, Burt JM, Hirschi KD et al. Gap junction communication mediates transforming growth factor-beta activation and endothelialinduced mural cell differentiation. Circ Res 2003; 93: 429-437.
39. Tacheau C, Fontaine J, Loy J et al. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways. J Cell Physiol 2008; 21: 759-768.
40. Stains JP, Civitelli R. Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription. Mol Biol Cell 2005; 16: 64-72.
41. Zhang Y, Wang H, Kovacs A et al. Reduced expression of Cx43 attenuates ventricular remodeling after myocardial infarction via impaired TGF-beta signaling. Am J Physiol Heart Circ Physiol 2010; 298: 477-487.
42. Dai P, Nakagami T, Tanaka H et al. Cx43 mediates TGF-beta signaling through competitive Smads binding to microtubules. Mol Biol Cell 2007; 18: 2264-2273.
43. Mori R, Power KT, Wang CM et al. Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci 2006; 119: 5193-5203.
44. Tsuchida S, Arai Y, Kishida T et al. Silencing the expression of connexin 43 decreases inflammation and joint destruction in experimental arthritis. J Orthop Res 2012; 31: 525-530.